K.J. Harrison & Partners’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,801
Closed -$1.44K 135
2023
Q2
$1.44K Sell
32,801
-38,666
-54% -$1.95K ﹤0.01% 215
2023
Q1
$2.21K Sell
71,467
-25,000
-26% -$1.41K ﹤0.01% 235
2022
Q4
$4.96K Hold
96,467
﹤0.01% 225
2022
Q3
$6K Hold
96,467
﹤0.01% 182
2022
Q2
$10K Sell
96,467
-5,000
-5% -$1.07K ﹤0.01% 215
2022
Q1
$25K Buy
101,467
+15,200
+18% +$6.54K ﹤0.01% 277
2021
Q4
$68K Buy
86,267
+25,765
+43% +$18.9K 0.01% 300
2021
Q3
$39K Buy
60,502
+40,502
+203% +$32.9K 0.01% 319
2021
Q2
$19 Buy
+20,000
New +$14.3K ﹤0.01% 320

Other funds holding COCHW

K.J. Harrison & Partners's COCHW Position: Q3 2023 in Review

K.J. Harrison & Partners sold out of Envoy Medical Warrant (COCHW) in Q3 2023, closing a stake of 32,801 shares — an estimated $1.44K sold.

K.J. Harrison & Partners first reported a position in COCHW in Q2 2021 and held it in 9 quarters. The position peaked at $68K in Q4 2021. 45 funds tracked by Wall St. Rank hold COCHW as of Q3 2023.

  • K.J. Harrison & Partners reported no remaining Envoy Medical Warrant position as of Q3 2023 after selling out during the quarter.
  • K.J. Harrison & Partners sold 32,801 Envoy Medical Warrant shares in Q3 2023, an estimated $1.44K.
  • K.J. Harrison & Partners first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 9 quarters.
  • K.J. Harrison & Partners's Envoy Medical Warrant position peaked at $68K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q3 2023.

Based on K.J. Harrison & Partners's 13F filing for Q3 2023, filed 31 Oct 2023.